Hans-Juergen Kruase

Title: Innovations of Hans-Juergen Kruase

Introduction

Hans-Juergen Kruase is a notable inventor based in Biblis, Germany. He has made significant contributions to the field of biotechnology, particularly in the formulation of human antibodies. His work is essential for advancing treatments for various medical conditions.

Latest Patents

Kruase holds a patent for the "Formulation of human antibodies for treating TNF-α associated disorders." This patent describes a liquid aqueous pharmaceutical formulation that boasts a high protein concentration, a pH range of about 4 to about 8, and enhanced stability. This innovation is crucial for developing effective therapies for patients suffering from TNF-α related disorders.

Career Highlights

Kruase is currently associated with Abbott Biotechnology Ltd., a leading company in the biotechnology sector. His role involves research and development, focusing on creating innovative solutions that address critical health challenges. His expertise and dedication have positioned him as a valuable asset in the field.

Collaborations

Kruase has collaborated with talented professionals, including Lisa Baust and Michael Dickes. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions.

Conclusion

Hans-Juergen Kruase's contributions to biotechnology through his innovative patent and collaborative efforts highlight his commitment to improving healthcare. His work continues to inspire advancements in medical treatments and showcases the importance of innovation in addressing health challenges.